Showing results (401-410 of 630) with videos related to
Sort By:
Pageof 63
Journal of the American College of Cardiology|April 30, 1998
Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agentsL Gregorini, J Marco, C Palombo, et al.Journal of Hypertension|June 14, 2001
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study GroupA Zanchetti, L Hansson, B Dahlöf, et al.Clinical Science (London, England : 1979)|December 1, 1979
Plasma catecholamines and blood pressure responses to the carotid baroreceptor reflex in essential hypertensionG Mancia, G Leonetti, G B Picotti, et al.International Angiology : a Journal of the International Union of Angiology|July 1, 1989
Angiosarcoma in a limb with arteriovenous fistulas and elephantiasisG L Faggioli, F Bertoni, P Bacchini, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 25, 2006
Carotid stent failure: results of surgical rescueG L Faggioli, M Ferri, C Rossi, et al.The Journal of Cardiovascular Surgery|May 1, 1992
Parietal inflammatory infiltrate in peripheral aneurysms of atherosclerotic originG L Faggioli, M Gargiulo, F Bertoni, et al.Research in Microbiology|October 18, 2012
Mutation of crp mediates Serratia marcescens serralysin and global secreted protein productionRobert M Q Shanks, Nicholas A Stella, Kristin E Arena, et al.Journal of Microbiological Methods|September 15, 2020
mCloverBlaster: A tool to make markerless deletions and fusions using lambda red and I-SceI in Gram-negative bacterial genomesKara M Lehner, Nicholas A Stella, Rachel C Calvario, et al.Canadian Journal of Microbiology|December 8, 2015
Exploitation of a "hockey-puck" phenotype to identify pilus and biofilm regulators in Serratia marcescens through genetic analysisRobert M Q Shanks, Nicholas A Stella, Kimberly M Brothers, et al.Clinical Immunology and Immunopathology|January 1, 1984
A placebo-controlled trial of thymic hormone treatment of recurrent herpes simplex labialis infection in immunodeficient host: results after a 1-year follow-upF Aiuti, M C Sirianni, M Fiorilli, et al.Pageof 63